INS and metabolic dysfunction-associated steatotic liver disease: On the other hand, there exists an enhanced risk of chronic noncommunicable disease as non-alcoholic fatty liver disease (NAFLD), a pathology characterized by the accumulation of fat in the liver, a condition strictly associated to the enhanced insulin resistance reported in DS individuals [15–17].